Arcus’s highest priority is to execute on its ongoing Phase 3 trial and overall development plan aimed at establishing casdatifan as the standard-of-care and backbone therapy for clear cell renal cell ...

Samsung Bioepis pursues direct sales by weighing Organon acquisition to boost profits Samsung Bioepis weighs buying Organon ...

SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...

Pathogens can create sticky situations. When microbes invade the body to cause an infection, often one of their first lines ...

Switching to a second TNF inhibitor in inflammatory bowel disease may raise the risk for immune-mediated inflammatory ...

This important study introduces a new biology-informed strategy for deep learning models aiming to predict mutational effects in antibody sequences. It provides solid evidence that separating ...

Proteins that are no longer needed, defective, or potentially harmful are labeled with a molecular "tag" and dismantled in ...

Cancer cells employ a variety of strategies to evade the immune system, and modern immunotherapies aim precisely at these ...

Researchers at the University of Southampton have developed a promising new way to bolster the body's immune system response to cancer.

“Orforglipron and retatrutide from Eli Lilly exemplify the next generation of metabolic therapies: oral formulations that promise improved adherence, triple-hormone mechanisms that deliver superior ...

TCL, a global leader in consumer electronics and the world's No. 1 Mini LED and ultra-large TV brand, today unveils a new generation of visual technology breakthroughs and AI-powered products at CES ...

Partnership has already generated high-quality, AI-ready data in less than three months ...